| Literature DB >> 35053734 |
Hwal Rim Jeong1, Hae Sang Lee2, Young Suk Shim2, Jin Soon Hwang2.
Abstract
We conducted this study to investigate the associations between hematological parameters and obesity in children and adolescents. The levels of hematological parameters (including white blood cells [WBCs], red blood cells [RBCs], hemoglobin [Hb], hematocrit [Hct], and platelets) of 7997 participants (4259 boys and 3738 girls) aged 10-18 years were recorded. The parameters were compared among participants with normal weight, overweight, and obesity. Significantly higher mean levels of WBCs (7.16 vs. 6.16 × 103/mm3, p < 0.001), RBCs (4.90 vs. 4.82 × 106/mm3, p < 0.001), Hb (14.07 vs. 13.99 g/dL, p < 0.05), Hct (42.31 vs. 41.91%, p < 0.001), and platelets (311.87 vs. 282.66 × 103/mm3, p < 0.001) were found in the obese than normal weight group, respectively, after adjusting for body mass index (BMI) and sex. BMI SDS had significant positive associations with the levels of WBCs (β = 0.275, p < 0.001), RBCs (β = 0.028, p < 0.001), Hb (β = 0.034, p < 0.001), Hct (β = 0.152, p < 0.001), and platelets (β = 8.372, p < 0.001) after adjusting for age, sex, and socioeconomic factors in a multiple linear regression analysis. A higher BMI was associated with elevated WBC, RBC, Hb, Hct, and platelet counts in children and adolescents. Because higher levels of hematological parameters are potential risk factors for obesity-related diseases, hematological parameters should be evaluated in obese children and adolescents.Entities:
Keywords: RBC; WBC; children; obesity; platelets
Year: 2022 PMID: 35053734 PMCID: PMC8774222 DOI: 10.3390/children9010109
Source DB: PubMed Journal: Children (Basel) ISSN: 2227-9067
Figure 1Flow chart of study population.
Clinical characteristics of the study participants by body weight (n = 7997).
| Normal Weight | Overweight | Obesity |
| |
|---|---|---|---|---|
| Total, | 6421 (80.29%) | 782 (9.78%) | 794 (9.93%) | |
| Boys, | 3350 (52.17%) | 443(56.65%) | 466 (58.69%) | <0.001 |
| Age (year) | 14.33 ± 2.51 | 14.24 ± 2.51 | 14.78 ± 2.54 | <0.001 |
| Height SDS | 0.17 ± 1.03 | 0.47 ± 1.04 | 0.53 ± 1.11 | <0.001 |
| Weight SDS | −0.31 ± 0.89 | 1.29 ± 0.49 | 2.20 ± 0.74 | <0.001 |
| BMI SDS (kg/m2) | −0.59 ± 0.88 | 0.86 ± 0.45 | 1.64 ± 0.75 | <0.001 |
| WC SDS | −0.49 ± 0.85 | 1.32 ± 0.18 | 2.40 ± 0.67 | <0.001 |
| SBP (mmHg) | 105.65 ± 9.77 | 109.94 ± 10.28 | 113.68 ± 10.95 | <0.001 |
| DBP (mmHg) | 65.59 ± 8.91 | 66.88 ± 8.88 | 69.07 ± 9.19 | <0.001 |
| WBC (×103/mm3) | 6.16 ± 1.49 | 6.65 ± 1.58 | 7.16 ± 1.65 | <0.001 |
| RBC (×106/mm3) | 4.81 ± 0.39 | 4.89 ± 0.40 | 4.93 ± 0.41 | <0.001 |
| Hemoglobin (g/dL) | 13.97 ± 1.23 | 14.07 ± 1.22 | 14.19 ± 1.30 | <0.001 |
| Hematocrit (%) | 41.86 ± 3.40 | 42.28 ± 3.42 | 42.65 ± 3.53 | <0.001 |
| Platelets (×103/mm3) | 282.96 ± 58.58 | 296.81 ± 59.92 | 309.03 ± 63.53 | <0.001 |
| Glucose (mg/dL) | 90.01 ± 7.39 | 91.83 ± 11.05 | 92.45 ± 12.16 | <0.001 |
| T-C (mg/dL) | 158.25 ± 26.27 | 163.00 ± 28.46 | 169.35 ± 29.50 | <0.001 |
| HDL-C (mg/dL) | 52.16 ± 9.94 | 47.68 ± 8.63 | 44.99 ± 8.37 | <0.001 |
| TG (mg/dL) | 79.29 ± 41.79 | 99.34 ± 54.29 | 112.75 ± 58.76 | <0.001 |
| LDL-C (mg/dL) | 90.24 ± 22.42 | 95.46 ± 25.07 | 101.81 ± 25.63 | <0.001 |
| Alcohol consumption | 1564 (24.36%) | 188 (24.04%) | 237 (29.85%) | 0.003 |
| Smoker | 718 (11.18%) | 88 (11.25%) | 106 (13.35%) | 0.191 |
| Household income ≤ 1st quartile | 687 (10.70%) | 82 (10.49%) | 95 (11.96%) | 0.531 |
| Rural residence | 985 (15.34%) | 113 (14.45%) | 125 (15.74%) | 0.757 |
| Physical activity | 2368 (36.88%) | 279 (35.68%) | 316 (39.80%) | 0.194 |
| Hypertension | 1 (0.02%) | 1 (0.13%) | 1 (0.13%) | 0.124 |
| T2DM | 0 (0%) | 0 (0%) | 0 (0%) | >0.999 |
| Dyslipidemia | 0 (0%) | 0 (0%) | 0 (0%) | >0.999 |
SDS, standard deviation score; BMI, body mass index; WC, waist circumference; SBP, systolic blood pressure; DBP, diastolic blood pressure; WBC, white blood cell; RBC, red blood cell; T-C, total cholesterol; HDL-C, high-density lipoprotein cholesterol; TG, triglycerides; LDL-C, low-density lipoprotein cholesterol; T2DM, type 2 diabetes mellitus.
Figure 2Mean white blood cell (WBC), red blood cell (RBC), hemoglobin, hematocrit, and platelet levels according to sex and obesity. (a), Mean white blood cell (WBC) according to sex and obesity; (b), Mean red blood cell (RBC) according to sex and obesity; (c), Mean hemoglobin levels according to sex and obesity; (d), Mean hematocrit levels according to sex and obesity; (e), Mean platelet levels according to sex and obesity; *, p < 0.05; **, p < 0.005; ***, p < 0.001; NS., p > 0.05.
Mean white blood cell (WBC), red blood cell (RBC), hemoglobin, hematocrit, and platelet levels according to sex and obesity.
| Boys | Girls | |||||
|---|---|---|---|---|---|---|
| NW | OW | OB | NW | OW | OB | |
| WBC (×103/mm3) | 6.13 ± 1.45 | 6.68 ± 1.53 a | 7.13 ± 1.60 b,c | 6.18 ± 1.53 | 6.61 ± 1.64 a | 7.22 ± 1.71 b,c |
| RBC (×106/mm3) | 5.02 ± 0.34 | 5.10 ± 0.34 a | 5.13 ± 0.33 c | 4.59 ± 0.31 | 4.62 ± 0.30 | 4.63 ± 0.31 c |
| Hemoglobin (g/dL) | 14.60 ± 1.11 | 14.64 ± 1.15 | 14.79 ± 1.20 c | 13.28 ± 0.96 | 13.33 ± 0.85 | 13.34 ± 0.92 |
| Hematocrit (%) | 43.43 ± 3.30 | 43.73 ± 3.38 | 44.18 ± 3.34 c | 40.15 ± 2.60 | 40.38 ± 2.42 | 40.49 ± 2.50 c |
| Platelet (×103/mm3) | 278.59 ± 58.48 | 295.33 ± 61.62 a | 302.91 ± 61.66 c | 287.73 ± 58.32 | 298.74 ± 57.65 a | 317.73 ± 65.21 b,c |
Data are presented as the mean ± standard deviation (SD). NW, underweight and normal weight; OW, overweight; OB, obesity; WBC, white blood cell; RBC, red blood cell. Bonferroni’s post-hoc test after adjustment for age among girls.a: p < 0.05, NW group versus OW group after Bonferroni’s post-hoc test. b: p < 0.05, OW group versus OB group after Bonferroni’s post-hoc test. c: p < 0.05, NW group versus OB group after Bonferroni’s post-hoc test.
Adjusted mean levels of white blood cells, red blood cells, hemoglobin, hematocrit, and platelets by sex and BMI.
| All Participants 1 | Normal Weight | Overweight | Obesity | |
|---|---|---|---|---|
| WBC (×103/mm3) | 6.16 ± 0.02 | 6.66 ± 0.05 a | 7.16 ± 0.05 b,c | <0.001 |
| RBC (×106/mm3) | 4.82 ± 0.01 | 4.88 ± 0.01 a | 4.90 ± 0.01 c | <0.001 |
| Hemoglobin (g/dL) | 13.99 ± 0.01 | 14.04 ± 0.04 | 14.07 ± 0.04 | 0.016 |
| Hematocrit (%) | 41.91 ± 0.04 | 42.21 ± 0.10 a | 42.31 ± 0.10 c | <0.001 |
| Platelets (×103/mm3) | 282.66 ± 0.72 | 296.38 ± 2.05 a | 311.87 ± 2.04 b,c | <0.001 |
|
| ||||
| ( | ||||
| WBC (×103/mm3) | 6.13 ± 0.03 | 6.69 ± 0.07 a | 7.12 ± 0.07 b,c | <0.001 |
| RBC (×106/mm3) | 5.02 ± 0.01 | 5.11 ± 0.01 a | 5.12 ± 0.01 c | <0.001 |
| Hemoglobin (g/dL) | 14.60 ± 0.01 | 14.72 ± 0.04 a | 14.72 ± 0.04 c | <0.001 |
| Hematocrit (%) | 43.43 ± 0.04 | 43.96 ± 0.12 a | 44.00 ± 0.12 c | <0.001 |
| Platelets (×103/mm3) | 278.64 ± 0.97 | 293.21 ± 2.66 a | 304.58 ± 2.59 b,c | <0.001 |
|
| ||||
| ( | ||||
| WBC (×103/mm3) | 6.18 ± 0.03 | 6.61 ± 0.08 a | 7.20 ± 0.09 b,c | <0.001 |
| RBC (×106/mm3) | 4.59 ± 0.01 | 4.62 ± 0.02 | 4.66 ± 0.02 c | <0.001 |
| Hemoglobin (g/dL) | 13.27 ± 0.02 | 13.34 ± 0.05 | 13.39 ± 0.05 | 0.015 |
| Hematocrit (%) | 40.14 ± 0.05 | 40.39 ± 0.14 | 40.59 ± 0.14 c | <0.001 |
| Platelets (×103/mm3) | 287.47 ± 1.05 | 298.90 ± 3.17 a | 319.95 ± 3.23 b,c | <0.001 |
Data are presented as the mean ± standard error (SE). WBC, white blood cell; RBC, red blood cell. Model 1: Comparisons with BMI using analysis of covariance with Bonferroni’s post-hoc test after adjustment for age and sex among all participants. Model 2: Comparisons with BMI using analysis of covariance with Bonferroni’s post-hoc test after adjustment for age among boys. Model 3: Comparisons with BMI using analysis of covariance with Bonferroni’s post-hoc test after adjustment for age among girls. a: p < 0.05 between normal weight vs. overweight group after Bonferroni’s post-hoc test. b: p < 0.05 between overweight vs. obesity group after Bonferroni’s post-hoc test. c: p < 0.05 between normal weight vs. obesity group after Bonferroni’s post-hoc test.
Unadjusted and adjusted correlations between body mass index (BMI) standard deviation score (SDS) and white blood cell (WBC), red blood cell (RBC), hemoglobin, hematocrit, and platelet levels.
| All Participants ( |
|
| ||
|---|---|---|---|---|
| WBC (×103/mm3) | 0.223 | <0.001 | 0.222 | <0.001 |
| RBC (×106/mm3) | 0.096 | <0.001 | 0.109 | <0.001 |
| Hemoglobin (g/dL) | 0.044 | <0.001 | 0.042 | <0.001 |
| Hematocrit (%) | 0.067 | <0.001 | 0.067 | <0.001 |
| Platelets (×103/mm3) | 0.169 | <0.001 | 0.180 | <0.001 |
|
|
|
|
| |
| WBC (×103/mm3) | 0.239 | <0.001 | 0.240 | <0.001 |
| RBC (×106/mm3) | 0.157 | <0.001 | 0.180 | <0.001 |
| Hemoglobin (g/dL) | 0.070 | <0.001 | 0.111 | <0.001 |
| Hematocrit (%) | 0.090 | <0.001 | 0.137 | <0.001 |
| Platelets (×103/mm3) | 0.175 | <0.001 | 0.177 | <0.001 |
|
|
|
|
| |
| WBC (×103/mm3) | 0.206 | <0.001 | 0.202 | <0.001 |
| RBC (×106/mm3) | 0.047 | 0.004 | 0.078 | <0.001 |
| Hemoglobin (g/dL) | 0.014 | 0.383 | 0.033 | 0.043 |
| Hematocrit (%) | 0.042 | 0.009 | 0.054 | <0.001 |
| Platelets (×103/mm3) | 0.164 | <0.001 | 0.176 | <0.001 |
WBC, white blood cell; RBC, red blood cell. 1: Pearson’s correlation analyses were conducted between BMI SDS and WBC, RBC, hemoglobin, hematocrit, and platelet levels with no adjustments. 2: Pearson’s correlation analyses were conducted between BMI SDS and WBC, RBC, hemoglobin, hematocrit, and platelet levels after adjustments for age and sex for all participants. 3: Pearson’s correlation analyses were conducted between BMI SDS and WBC, RBC, hemoglobin, hematocrit, and platelet levels with no adjustments in boys. 4: Pearson’s correlation analyses were conducted between BMI SDS and WBC, RBC, hemoglobin, hematocrit, and platelet levels after adjustment for age in boys. 5: Pearson’s correlation analyses were conducted between BMI SDS and WBC, RBC, hemoglobin, hematocrit, and platelet levels with no adjustments. 6: Pearson’s correlation analyses were conducted between BMI SDS and WBC, RBC, hemoglobin, hematocrit, and platelet levels after adjustment for age in girls.
Multiple regression analysis of the associations of body mass index (BMI) standard deviation score (SDS) with white blood cell (WBC), red blood cell (RBC), hemoglobin, hematocrit, and platelet levels.
| All Participants 1 | Β | SE |
|
|---|---|---|---|
| WBC (×103/mm3) | 0.275 | 0.013 | <0.001 |
| RBC (×106/mm3) | 0.028 | 0.003 | <0.001 |
| Hemoglobin (g/dL) | 0.034 | 0.009 | <0.001 |
| Hematocrit (%) | 0.152 | 0.025 | <0.001 |
| Platelet (×103/mm3) | 8.372 | 0.510 | <0.001 |
| WBC (×103/mm3) | 0.279 | 0.017 | <0.001 |
| RBC (×106/mm3) | 0.043 | 0.004 | <0.001 |
| Hemoglobin (g/dL) | 0.073 | 0.010 | <0.001 |
| Hematocrit (%) | 0.267 | 0.030 | <0.001 |
| Platelet (×103/mm3) | 7.658 | 0.657 | <0.001 |
| WBC (×103/mm3) | 0.270 | 0.021 | <0.001 |
| RBC (×106/mm3) | 0.019 | 0.004 | <0.001 |
| Hemoglobin (g/dL) | 0.027 | 0.013 | 0.038 |
| Hematocrit (%) | 0.118 | 0.035 | <0.001 |
| Platelet (×103/mm3) | 8.715 | 0.798 | <0.001 |
WBC, white blood cell; RBC, red blood cell. 1: Multiple linear regression analysis was conducted between BMI SDS (independent variable) and WBC, RBC, hemoglobin, hematocrit, and platelet levels (dependent variables) after adjustments for age, sex, alcohol consumption, smoking, physical activity, rural residence, household income, type 2 diabetes mellitus (T2DM), hypertension, and dyslipidemia for all participants. 2: Multiple linear regression analysis was conducted between BMI SDS (independent variable) and WBC, RBC, hemoglobin, hematocrit, and platelet levels (dependent variables) after adjustments for age, sex, alcohol consumption, smoking, physical activity, rural residence, household income, T2DM, hypertension, and dyslipidemia among boys. 3: Multiple linear regression analysis was conducted between BMI SDS (independent variable) and WBC, RBC, hemoglobin, hematocrit, and platelet levels (dependent variables) after adjustments for age, sex, alcohol consumption, smoking, physical activity, rural residence, household income, diagnosis of T2DM, hypertension, and dyslipidemia among girls.